You just read:

Spiral Therapeutics Acquires an Exclusive Option to Develop Two Neuroprotective Agents for the Treatment of Inner Ear Disorders

News provided by

Spiral Therapeutics, Inc.

29 Mar, 2017, 09:00 ET